Difference between revisions of "HemOnc vocabulary concepts"
m |
|||
| Line 8: | Line 8: | ||
==Context== | ==Context== | ||
Examples: adjuvant therapy, non-curative first-line induction therapy, upfront therapy | Examples: adjuvant therapy, non-curative first-line induction therapy, upfront therapy | ||
| − | |||
| − | |||
=Regimen-level concepts= | =Regimen-level concepts= | ||
| Line 30: | Line 28: | ||
==Component Class== | ==Component Class== | ||
Examples: 5 alpha-reductase inhibitor, AKT1 inhibitor, anthracycline | Examples: 5 alpha-reductase inhibitor, AKT1 inhibitor, anthracycline | ||
| + | ==Procedure== | ||
| + | Examples: adrenalectomy, lymphadenectomy, interval debulking surgery | ||
==Rad Sig== | ==Rad Sig== | ||
Example: 1.1 Gy fractions x 70 fractions, given twice per day, 5 times per week (total dose: 77 Gy) | Example: 1.1 Gy fractions x 70 fractions, given twice per day, 5 times per week (total dose: 77 Gy) | ||
| Line 46: | Line 46: | ||
==Study== | ==Study== | ||
Examples: ABSOLUTE, ACOSOG Z1031, ECOG E3483 | Examples: ABSOLUTE, ACOSOG Z1031, ECOG E3483 | ||
| + | ==Study Class== | ||
| + | Example: FDA registration study | ||
==Study Group== | ==Study Group== | ||
Examples: Eastern Cooperative Oncology Group, EINSTEIN Investigators, EORTC Children Leukemia Group | Examples: Eastern Cooperative Oncology Group, EINSTEIN Investigators, EORTC Children Leukemia Group | ||
| Line 53: | Line 55: | ||
=Publication-level concepts= | =Publication-level concepts= | ||
==Journal== | ==Journal== | ||
| + | Examples: Blood Adv, N Engl J Med, Ann Oncol | ||
==PubMedURL== | ==PubMedURL== | ||
| + | Example: https://www.ncbi.nlm.nih.gov/pubmed/10202164 | ||
==Reference== | ==Reference== | ||
| + | Examples: ABSOLUTE::00, Abrey et al. 2000::01 | ||
==ReferenceTitle== | ==ReferenceTitle== | ||
| + | Example: A comparative study of two regimens of combination chemotherapy in acute leukemia | ||
==ReferenceURL== | ==ReferenceURL== | ||
| − | + | Example: http://ar.iiarjournals.org/content/31/6/2297.long | |
=Author-level concepts= | =Author-level concepts= | ||
==Author== | ==Author== | ||
| − | + | Author names, in the format of Last-Name_First/Middle. | |
| + | *Examples: Abbruzzese_Alberto, Abbruzzese_James L, Abernethy_Amy | ||
=Generic concepts= | =Generic concepts= | ||
==Year== | ==Year== | ||
| + | Examples: 1946, 2020 | ||
[[Category:Ontology pages]] | [[Category:Ontology pages]] | ||
Revision as of 20:48, 27 January 2020
This page has short descriptions and examples of the concepts that have been parsed into the HemOnc ontology. Note that this is NOT the full HemOnc chemotherapy regimen model, as there are still concepts that are in the process of being defined and parsed. For information about how to obtain a copy of the ontology please go to this page.
Condition-level concepts
Condition
Examples: acquired coagulopathy, acute myeloid leukemia, adrenocortical carcinoma
Condition Class
Examples: classical hematologic condition, leukemia, malignant solid neoplasm
Context
Examples: adjuvant therapy, non-curative first-line induction therapy, upfront therapy
Regimen-level concepts
Cycle Sigs
Examples: 14-day cycle for up to 8 cycles, 21-day cycle for 4 cycles, 21-day cycle for up to 35 cycles (2 years)
Modality
Examples: anticoagulation, chemotherapy, immunotherapy
Regimen
Examples: 7 plus 3d, 7 plus 3d and Midostaurin, R-CHOP
Regimen Class
Examples: platinum doublet, bevacizumab-containing regimen
Regimen Stub
Examples: FULV and Trimetrexate, Plitidespin and Dexamethasone
Component-level concepts
Brand Name
Examples: Abatoarin, Acetisal, Aclacin
Component
Examples: abciximab, abemaciclib, abexinostat
Component Class
Examples: 5 alpha-reductase inhibitor, AKT1 inhibitor, anthracycline
Procedure
Examples: adrenalectomy, lymphadenectomy, interval debulking surgery
Rad Sig
Example: 1.1 Gy fractions x 70 fractions, given twice per day, 5 times per week (total dose: 77 Gy)
Route
Examples: intravenous, oral, subcutaneous
Sig
Example: 0.4 mg/m^2/day IV continuous infusion over 96 hours, started on day 1 (total dose per cycle: 1.6 mg/m^2)
Sig Stub
Example: (dose not specified) IT once per day on days 22 and 43
Study-level concepts
Endpoint
Examples: CR rate after first induction, DFS36, OS
Experimental design
Examples: de-escalation, escalation, in-class switch, out-of-class switch
Study
Examples: ABSOLUTE, ACOSOG Z1031, ECOG E3483
Study Class
Example: FDA registration study
Study Group
Examples: Eastern Cooperative Oncology Group, EINSTEIN Investigators, EORTC Children Leukemia Group
Study name short
Examples: Adelstein et al. 2003, Adelstein et al. 2010, Alberts et al. 1989
Publication-level concepts
Journal
Examples: Blood Adv, N Engl J Med, Ann Oncol
PubMedURL
Example: https://www.ncbi.nlm.nih.gov/pubmed/10202164
Reference
Examples: ABSOLUTE::00, Abrey et al. 2000::01
ReferenceTitle
Example: A comparative study of two regimens of combination chemotherapy in acute leukemia
ReferenceURL
Example: http://ar.iiarjournals.org/content/31/6/2297.long
Author-level concepts
Author
Author names, in the format of Last-Name_First/Middle.
- Examples: Abbruzzese_Alberto, Abbruzzese_James L, Abernethy_Amy
Generic concepts
Year
Examples: 1946, 2020